In the cohort study conducted at three clinical sites in France, the correlation between antibiotic treatment and the efficacy of PD-1-based therapy was investigated on 249 patients with epithelial cancers including non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) and urothelial carcinoma [66]. The gene discussed is PDCD1; the disease is renal cell carcinoma.